Related references
Note: Only part of the references are listed.Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial Infarction
Pia R. Kamstrup et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease
Robert Clarke et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Lipoprotein(a) levels and risk of future coronary heart disease
Anna Bennet et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
New insights into the role of lipoprotein(a)-associated lipoprotein-associated phospholipase A2 in atherosclerosis and cardiovascular disease
Sotirios Tsimikas et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
A polymorphism in the protease-like domain of apolipoprotein(a) is associated with severe coronary artery disease
May M. Luke et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase a2 activity, and 10-year cardiovascular outcomes - Prospective results from the Bruneck study
Stefan Kiechl et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
The metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein (a) in human beings
LJ Jenner et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2005)
Apolipoprotein(a) size and lipoprotein(a) concentration and future risk of angina pectoris with evidence of severe coronary atherosclerosis in men: The physicians' health study
N Rifai et al.
CLINICAL CHEMISTRY (2004)
First WHO/IFCC International Reference Reagent for Lipoprotein(a) for Immunoassay - Lp(a) SRM 2B
F Dati et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2004)
Lipoprotein(a) as a risk factor for atherosclerosis and thrombosis: mechanistic insights from animal models
MB Boffa et al.
CLINICAL BIOCHEMISTRY (2004)
Analysis of the apo(a) size polymorphism in Asian Indian populations: association with Lp(a) concentration and coronary heart disease
FS Geethanjali et al.
ATHEROSCLEROSIS (2003)
Lp(a) particles mold fibrin-binding properties of Apo(a) in size-dependent manner -: A study with different-length recombinant Apo(a), native Lp(a), and monoclonal antibody
C Kang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
The structure of haplotype blocks in the human genome
SB Gabriel et al.
SCIENCE (2002)
Serum lipids, lipoprotein(a) level, and apolipoprotein(a) isoforms as prognostic markers in patients with coronary heart disease
U Lundstam et al.
JOURNAL OF INTERNAL MEDICINE (2002)
Serum lipoprotein(a) concentrations and apolipoprotein(a) isoforms: association with the severity of clinical presentation in patients with coronary heart disease
CS Katsouras et al.
JOURNAL OF CARDIOVASCULAR RISK (2001)
Share Paper
